Business · 1 sources covering this

Dr Reddy's launches generic oral leukaemia drug Bosutinib in US market

The company has launched a generic version of Pfizer's Bosulif for chronic myeloid leukaemia and secured 180 days of exclusivity for the 400 mg strength

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·4h ago
Dr Reddy's launches generic oral leukaemia drug Bosutinib in US market
The company has launched a generic version of Pfizer's Bosulif for chronic myeloid leukaemia and secured 180 days of exclusivity for the 400 mg strength
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/e93b5284d0055db82ec5a63644e9b30723b9145e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Dr Reddy's launches generic oral leukaemia drug Bosutinib in US market"></iframe>

Dr Reddy's launches generic oral leukaemia drug Bosutinib in US market

How 1 sources are covering this

Dr Reddy's launches generic oral leukaemia drug Bosutinib in US market

More from Business

PM Modi, Donald Trump To Meet On G7 Sidelines In France, May Discuss Trade

Gill races to 3,000: A record for the ages

Earning Rs 1 Lakh? How The 'Invest First' Rule Can Make You Rs 45 Lakh Richer In 10 Years

West Indies Vs New Zealand Live Streaming: How To Watch ICC Women's T20 World Cup Match On TV, Online?

Reader

Trust & legal

Across the network